2023 Speakers

Dr. Kristi Hustak provides surgical and non-surgical procedures for the face, body and breasts to patients in Houston, Texas. As a multiple award winning, Board Certified Plastic Surgeon, she has been recognized annually over many platforms, such as Top Doctors – Plastic Surgery, Texas Monthly Super Doctors, My Face, My Body Awards, H Texas Top…

Dr. Parrish leads the corporate development strategy and operations for Merz Aesthetics. Since joining Merz in 2009, Dr. Parrish has worked in a variety of sales, marketing and business/corporate development roles, including an international assignment at Merz headquarters in Frankfurt, Germany. Prior to joining Merz, Dr. Parrish was a consultant at Navigant Consulting (formerly Easton…

Megan Driscoll is the CEO + Founder of EvolveMKD, an award-winning public relations and digital marketing agency based in New York City. She has 21 years of experience working with brands in the healthcare, prestige beauty and lifestyle industries. Key to her success is Megan’s ability to always find a way. Megan finds potential in…

Micah leads the Strategy and Pipeline function within Allergan Aesthetics, which encompasses global commercial development/upstream marketing, external innovation, and research and analytics. Prior to this role, he lead AbbVie’s enterprise innovation function, charged with supporting high-priority strategic issues across the organization. Micah joined AbbVie in 2019 after 7 years at consultancy McKinsey & Company, where…

Xiaoming Lin has more than 20 years of experience in developing dermatology products, with a focus on the minimally invasive aesthetic space. She has led the development of many products throughout her career, including work on three neuromodulators and multiple dermal fillers. Prior to her current role, she served as Vice President of Aesthetics Development…

Global Topic lead for BCG’s Medical Aesthetics Core member of HealthCare and Private Equity practice areas 15+ years of experience in beauty and aesthetics growth strategy/M&A, portfolio analysis, commercial models, GTM, pricing, loyalty programs, and digital acquisition of consumers

Rui Avelar, MD has served as Chief Medical Officer of Evolus since January 2014 along with being names Head of Research and Development in August 2018. From 2014 to 2018, he also served as the Chief Medical Officer of ALPHEAON. From 2011 to 2013, Rui served as Chief Medical Officer of Allergan Medical, where he…

Dr. Mitchell Brin serves as Senior Vice President, R&D and Chief Scientific Officer, BOTOX® and Neurotoxins at AbbVie. In this role, he provides cross-functional strategic leadership of BOTOX® and neurotoxins across the continuum of R&D through commercialization and manufacturing. He also leads the Neurotoxin Franchise Strategy Team (NFST), which supports strategic integration and alignment across…

Kristen B. Slaoui, PhD has been the Chief Corporate Development Officer at Galderma, the world’s largest independent global dermatology company, since 2020. Since joining Galderma, she oversaw several significant transactions including the acquisition of Alastin Skincare in 2021, adding to Galderma’s premium portfolio. Prior to this role, she spent 20 years with GSK, first in…

Karen Long is a Managing Director at KCK (Med Tech) Group. KCK focuses capital investment on commercial and growth stage medical device companies. Karen has been with KCK since January 2018 when she joined as Executive-in-Residence. Karen serves as Board Director in a number of KCK portfolio companies as well as Independently. Prior to KCK,…